Vanda (NASDAQ: VNDA) investors approve directors, auditor and equity plan shares
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Vanda Pharmaceuticals Inc. reported the results of its 2026 annual stockholder meeting held on June 4, 2026. Stockholders elected three Class II directors—Richard W. Dugan, Charles C. Duncan, Ph.D., and Anne Sempowski Ward—to serve until the 2029 annual meeting.
PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Stockholders also approved, on an advisory, non-binding basis, the compensation of the company’s named executive officers and approved an amendment to the 2016 Equity Incentive Plan increasing the shares authorized for issuance.
A quorum was present, with 48,509,906 of 60,135,062 eligible common shares, or approximately 80.7%, represented in person or by proxy.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares entitled to vote: 60,135,062 shares
Shares represented: 48,509,906 shares
Equity plan amendment support: 31,729,991 votes for
+5 more
8 metrics
Shares entitled to vote
60,135,062 shares
Common stock entitled to vote at 2026 annual meeting
Shares represented
48,509,906 shares
Shares represented in person or by proxy; approximately 80.7%
Equity plan amendment support
31,729,991 votes for
Proposal 4 to increase shares under 2016 Equity Incentive Plan
Say-on-pay support
35,242,659 votes for
Advisory approval of named executive officer compensation
Auditor ratification support
48,103,698 votes for
Ratification of PricewaterhouseCoopers LLP for fiscal year 2026
Director votes – Dugan
33,029,049 votes for
Election of Richard W. Dugan as Class II director
Director votes – Duncan
35,780,031 votes for
Election of Charles C. Duncan, Ph.D., as Class II director
Director votes – Ward
33,897,782 votes for
Election of Anne Sempowski Ward as Class II director
Key Terms
broker non-votes, advisory, non-binding basis, independent registered public accounting firm, Equity Incentive Plan, +1 more
5 terms
broker non-votes financial
"The votes regarding the election of directors were as follows"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
advisory, non-binding basis financial
"The approval on an advisory, non-binding basis of the compensation"
independent registered public accounting firm financial
"PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Equity Incentive Plan financial
"amendment to the Company’s Amended and Restated 2016 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
quorum financial
"were represented at the meeting in person or by proxy, constituting a quorum"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
FAQ
What did Vanda Pharmaceuticals (VNDA) stockholders vote on at the 2026 annual meeting?
Stockholders voted on four items: electing three Class II directors, ratifying PricewaterhouseCoopers LLP as auditor for 2026, approving executive compensation on an advisory basis, and approving an amendment to the 2016 Equity Incentive Plan to increase shares authorized for issuance.
Were all director nominees elected at Vanda Pharmaceuticals’ 2026 annual meeting?
Yes, all three Class II director nominees were elected. Richard W. Dugan, Charles C. Duncan, Ph.D., and Anne Sempowski Ward each received more votes for than against, with additional broker non-votes reported but not counting as votes against their election.
Did Vanda Pharmaceuticals (VNDA) stockholders approve the 2016 Equity Incentive Plan amendment?
Yes, stockholders approved the amendment to increase shares under the 2016 Equity Incentive Plan. The proposal received 31,729,991 votes for, 6,685,078 against, and 78,020 abstentions, with 10,016,817 broker non-votes recorded but not counted as votes against the amendment.
Was PricewaterhouseCoopers LLP ratified as Vanda Pharmaceuticals’ auditor for 2026?
Yes, PricewaterhouseCoopers LLP was ratified as independent registered public accounting firm for 2026. The ratification received 48,103,698 votes for, 340,513 against, and 65,695 abstentions from stockholders, confirming continued engagement for the fiscal year ending December 31, 2026.
Did Vanda Pharmaceuticals (VNDA) stockholders approve executive compensation in 2026 say-on-pay vote?
Yes, stockholders approved named executive officer compensation on an advisory, non-binding basis. The proposal received 35,242,659 votes for, 3,167,243 against, and 83,187 abstentions, with 10,016,817 broker non-votes recorded consistent with typical say-on-pay voting mechanics.